Afrezza

Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Yahoo/AP
Wed, 08/14/13 - 09:17 am
insulin
diabetes MannKind
Afrezza
inhaled insulin
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
MannKind
Vical
clinical trials
GTx
diabetes
Afrezza
melanoma
Allovectin-7
enobosarm
lung cancer-related muscle wasting
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
BIOD-123
Biodel
MannKind
Afrezza
GTx
[video]Inhaled Insulin: Biotech Triumph or Future Flop?
Motley Fool
Mon, 07/8/13 - 10:37 am
inhaled insulin
Afrezza
MannKind
diabetes
Summer Street 'much more optimistic' about MannKind approval
The Fly on the Wall
Fri, 06/21/13 - 09:15 am
MannKind
drug approvals
Afrezza
diabetes
2 Biotech Approval Outcomes That Might Affect You
Motley Fool
Wed, 06/19/13 - 11:08 am
drug approvals
Afrezza
MannKind
Contrave
Orexigen
Can Mannkind Deliver A Summer Blockbuster?
Seeking Alpha
Tue, 06/11/13 - 09:16 am
MannKind
diabetes
Afrezza
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
MannKind: It All Comes Down To This
Seeking Alpha
Wed, 06/5/13 - 12:17 pm
MannKind
Afrezza
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
Yahoo
Fri, 05/31/13 - 04:37 pm
type 1 diabetes
MannKind
Afrezza
inhaled insulin
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
MannKind's Afrezza And The Oramed Threat
Seeking Alpha
Thu, 05/23/13 - 10:29 am
MannKind
Afrezza
diabetes
Oramed Pharmaceuticals
ORMD-0801
MannKind's Countdown to Liftoff?
Motley Fool
Fri, 05/10/13 - 12:40 pm
MannKind
Afrezza
3 Drug Catalysts to Watch in 2013
Motley Fool
Fri, 05/10/13 - 08:58 am
MannKind
Merck
Pfizer
Sanofi
Rigel Pharmaceuticals
suvorexant
insomnia
diabetes
Afrezza
fostamatinib
rheumatoid arthritis
MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It
TheStreet.com
Wed, 04/17/13 - 10:56 am
MannKind
inhaled insulin
Afrezza
diabetes
MannKind's Afrezza Likely To Easily Gain Approval
Seeking Alpha
Mon, 04/15/13 - 08:51 am
MannKind
inhaled insulin
diabetes
Afrezza
MannKind's Afrezza Likely To Fail AFFINITY 1 Phase III Trial
Seeking Alpha
Fri, 04/12/13 - 09:51 am
MannKind
Afrezza
diabetes
inhaled insulin
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind

Pages